Our in vitro findings highlight the dysregulation of FOXO1 as a shared feature of ALS patient-derived myoblasts and synthetic TDP-43 and FUS deficient myoblasts. The gene discussed is FOXO1; the disease is amyotrophic lateral sclerosis.